Recro Pharma Inc. (REPH) 10.71 $REPH Nasdaq stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Recro Pharma Inc. (REPH) 10.71 $REPH

Nasdaq stocks posting largest percentage decreases
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
ALDX: 9.30 (-1.45), ASMB: 16.78 (-2.76), HEES: 24.98 (-1.82), VLTC: 15.14 (-1.04), REPH: 10.71 (-0.78), ADTN: 16.61 (-1.92), CREE: 32.36 (-3.04)

Tetraphase Pharmaceuticals Appoints Gerri Henwood to Board of Directors
GlobeNewswire - Wed Apr 15, 4:15PM CDT
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced the appointment of Gerri Henwood, President and Chief Executive Officer of Recro Pharma, to the Company's Board of Directors. Ms. Henwood brings more than 30 years' experience in product commercialization, clinical development and regulatory approval processes to the Board. She replaces Steven Gullans, co-founder and partner of Excel Venture Fund.
TTPH: 39.96 (-0.50), REPH: 10.71 (-0.78)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:44AM CDT

NPD: 2.87 (+0.25), TEAR: 2.39 (+0.08), UQM: 1.02 (-0.02), ASPS: 18.07 (+1.32), CPHR: 11.34 (+0.44), SYRX: 2.09 (-0.05), CHOP: 3.67 (-0.26), NTLS: 5.46 (+0.17), HKTV: 7.67 (-0.33), PME: 1.88 (-0.12), CALI: 1.38 (+0.01), GBSN: 4.98 (+1.44), CTSO: 7.13 (-0.06), ORMP: 7.25 (-0.10), CYTX: 0.96 (-0.09), EXA: 11.49 (+0.01), BAS: 7.88 (+0.07), ENRJ: 1.75 (+0.05), BLDR: 13.00 (-0.09), REPH: 10.71 (-0.78)

Recro Pharma completes acquisition of certain Alkermes assets; Shares rise
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 10:02AM CDT

REPH: 10.71 (-0.78)

Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes
GlobeNewswire - Mon Apr 13, 6:00AM CDT
- Transformative Acquisition Diversifies Recro Pharma's Development Risk with Second, Complementary Acute Pain Product
ALKS: 62.60 (-0.24), REPH: 10.71 (-0.78)

Recro Pharma reduces enrollment target in study of lead product candidate; Results expected by mid-year
Seeking Alpha - at Seeking Alpha - Fri Apr 10, 11:26AM CDT

REPH: 10.71 (-0.78)

Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
GlobeNewswire - Thu Apr 09, 6:00AM CDT
Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain today announced that it had completed the prespecified interim analysis conducted on the Company's Phase II, double-blind REC-14-013 trial of Dex-IN in patients who initiate dosing of study medication on Post Op Day 1 following bunionectomy surgery. The purpose of the interim analysis was to allow for a sample size adjustment, if necessary, to maintain the ability to detect a difference in treatment effects between Dex-IN and placebo. The trial was expected to enroll approximately 200-250 patients. As a result of the interim analysis, the total enrollment for the trial was adjusted to approximately 170 patients.
REPH: 10.71 (-0.78)

Can the Rally in Recro Pharma (REPH) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 06, 8:40AM CDT
Can the Rally in Recro Pharma (REPH) Shares Continue?
REPH: 10.71 (-0.78)

Recro Pharma Q4 and FY14 results
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 8:16AM CDT

REPH: 10.71 (-0.78)

Recro Pharma beats by $0.23
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 7:05AM CDT

REPH: 10.71 (-0.78)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 342

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 423

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

FG Nexus Unveils Major $200 Million Stock Buyback Initiative

Updated Category News Views 141

FG Nexus Announces $200 Million Share Repurchase Program Today, FG Nexus Inc. (Nasdaq: FGNX, FGNXP) has revealed a robust initiative, aiming to repurchase up to $200 million of its own common stock. This program has been officially sanctioned by the company's Board of Directors and offers an open-ended framework for share buyback activities. Strategic Repurchase Approach...

Continue Reading
Innovative ETF Launch for Enhanced Market Stability

Updated Category News Views 162

New Era of ETF Investment Solutions WEBs Investments Inc., an innovator in volatility-managed investment solutions, in collaboration with Westwood Holdings Group, has recently unveiled a transformative series of exchange-traded funds (ETFs). This initiative aims to align closely with today's dynamic market conditions and cater to the evolving needs of investors....

Continue Reading
Exploring Jovi Greene's Emotional Journey in 'Pink Ponies'

Updated Category News Views 466

Jovi Greene Unveils New Single 'Pink Ponies' Rising country star Jovi Greene is making significant strides in the music industry with his latest single, 'Pink Ponies.' Following his successful debut with 'Two Tone Top,' this new release aims to inspire listeners by encouraging them to hold onto their dreams while cherishing their childhood memories. Jovi is excited to...

Continue Reading
Zoetis and Danone Forge Partnership to Transform Dairy Farming

Updated Category News Views 759

Innovation in Dairy Farming Through Strategic Collaboration In a significant move for sustainable agricultural practices, Zoetis and Danone have announced their collaborative efforts aimed at revolutionizing dairy farming through genetic advancements. This strategic partnership merges Danone's dedication to environmental care with Zoetis' cutting-edge expertise in animal...

Continue Reading
Exploring the Booming Market of Running Apps and Trends

Updated Category News Views 327

The Growing Demand for Running Apps The Running Apps Market is currently segmented by type, including iOS and Android platforms, as well as by application type, categorized between amateur and professional runners. The increasing awareness of health and fitness is significantly contributing to the sustenance and growth of this vibrant market. Market Size and Projections...

Continue Reading